Table 3.
Microbiology test results
| n | Prevalence in % (95%CI) | |
|---|---|---|
| Throat swabs (N = 104) | ||
| MRSA | 7 | 6.7 (3.3; 13.3) |
| Corynebacterium diphtheriae | 0 | NA |
| Faeces - Bacteria and antimicrobial-resistance (N = 48) | ||
| Escherichia coli | 6 | 12.5 (5.9; 24.7) |
| ESBL-producing Escherichia coli | 1 | 2.1 (0.1; 10.9) |
| CPO | 0 | NA |
| Faeces - Parasites (N = 41) | ||
| Blastocystis spp. | 28 | 68.3 (53.0; 80.4) |
| Blastocystis subtype 1 | 5 | 12.2 (5.3; 25.5) |
| Blastocystis subtype 2 | 9 | 22.0 (12.0; 36.7) |
| Blastocystis subtype 3 | 14 | 34.1 (21.6; 49.5) |
| Dientamoeba fragilis | 9 | 22.0 (12.0; 36.7) |
| Entamoeba dispar | 1 | 2.4 (1.3; 12.6) |
| Entamoeba coli | 6 | 14.6 (6.9; 28.4) |
| Endolimax nana | 3 | 7.3 (2.5; 19.4) |
| Entamoeba hartmanni | 3 | 7.3 (2.5; 19.4) |
| Giardia duodenalis | 3 | 7.3 (2.5; 19.4) |
| Iodamoeba bütschlii | 1 | 2.4 (1.3; 12.6) |
Abbreviations: ESBL, Extended-spectrum beta-lactamase; CPO, Carbapenemase-producing organisms; MRSA, Methicillin-resistant Staphylococcus aureus; NA, not applicable.